Published Jul 19, 2026, 7:48 PM ET · Updated 4 months ago · 3 sources
Samsung Biologics Agrees to Buy PolyPeptide in $1.8 Billion Deal
bloomberg
·
Original Report
Samsung Biologics Co. has agreed to acquire Switzerland’s PolyPeptide Group AG in an all-cash deal that values the contract drugmaker’s equity at about 1.46 billion Swiss francs ($1.8 billion), expanding its manufacturing capabilities.